Geneva—24/04/2015—Today, as part of World Malaria Day commemorations, the Roll Back Malaria (RBM) Partnership launches a Global Call to Action to increase national coverage with preventive treatment to protect pregnant women and their unborn children from the devastating outcomes caused by malaria during pregnancy.
Intermittent preventive treatment in pregnancy (IPTp) – which involves administering three doses of an antimalarial called sulfadoxine-pyrimethamine as early as possible during the 2nd trimester of pregnancy and at every scheduled visit to an antenatal clinic thereafter, saves lives. Specifically, IPTp reduces anaemia and increases the likelihood of babies being born at a healthy weight, thereby resulting in greater child survival . IPTp is recommended by the World Health Organization (WHO), together with insecticide treated bednets for the prevention of malaria during pregnancy.
RBM partnership launches Global Call to Action for malaria during pregnancy PDF
